The Video-On-Demand has been expired. If you would like to view any sessions related to WCN 2023, please don't hesitate to contact infowcn@theisn.org.
 

Late Breaking Clinical Trials Session

1 Apr 2023 14:15 15:15
Plenary Halls 2 & 3
Liz Lightstone Chairperson Imperial College London and Hammersmith HospitalUnited Kingdom
Sydney Tang Chairperson The University of Hong KongHong Kong, China
Time Session
14:15
14:25
STOP-ACEi Study
Sunil Bhandari Speaker Hull & East Yorkshire Hospitals NHS Trust United Kingdom
Plenary Halls 2 & 3
14:25
14:30
Q and A
Plenary Halls 2 & 3
14:30
14:40
DETERMINANTS OF THE EFFECTS OF SGLT2i ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL
Natalie Staplin Free Communication University of OxfordUnited Kingdom
Plenary Halls 2 & 3
14:40
14:45
Q and A
Plenary Halls 2 & 3
14:45
14:55
SPARSENTAN REDUCES PROTEINURIA IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IGAN): INTERIM RESULTS OF THE PROTECT STUDY
Muh Geot Wong Speaker University of SydneyAustralia
Plenary Halls 2 & 3
14:55
15:00
Q and A
Plenary Halls 2 & 3
15:00
15:10
RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF ARTESUNATE IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
Jianwen YU Free Communication The First Affiliated Hospital of Sun Yat-sen UniversityChina
15:10
15:15
Q and A
Plenary Halls 2 & 3